A Case Narrative on Left Shoulder Hand Syndrome
Arya Lekshmi. U.S.1, Hima Santhosh1, Anusree Raj R.S.2
15th Year Pharm D, Department of Pharmacy Practice, Ezhuthachan College of Pharmaceutical Sciences.
2Assistant Professor, Department of Pharmacy Practice, Ezhuthachan College of Pharmaceutical Sciences.
*Corresponding Author E-mail: himasherly@gmail.com, aryaamjithsatheesh99@gmail.com
ABSTRACT:
Background: The case report deals with Shoulder-hand syndrome
which is relatively a rare clinical entity classified as a type 1 complex
regional pain syndrome and it shows manifestations like a painful 'frozen
shoulder' with disability, swelling, vasomotor or dystrophic changes in the
homolateral hand. The pathophysiology of this
syndrome isn't well understood but may involve a predominant sympathetic factor
affecting the neural and vascular supply to the affected parts. Symptoms
include pain, swelling, redness, noticeable changes in temperature and
hypersensitivity (particularly to cold and touch).
Case Presentation: A 52 year old female
patient was admitted in general medicine department with complaints of neck
pain for 1½ years, edema in both legs and restriction in movement of the left
shoulder. She had a medical history of diabetes and hypertension. Conclusion: Early diagnosis and treatment is most
effective and can completely reverse the disease progression. The current
therapy mainly focusses on alleviating the signs and symptoms of the disease
rather than actual cure.
KEYWORDS: Left Shoulder Hand Syndrome.
BACKGROUND:
Shoulder-hand syndrome, also referred to asreflex sympathetic dystrophy, sudeck’s atrophy or causalgia, is a relatively rare clinical entity which is classified as a type 1 complex regional pain syndrome and it shows manifestations like a painful 'frozen shoulder' with disability, swelling, vasomotor or dystrophic changes in the homolateral hand1,2. Mostlythis complex pain syndrome develops after myocardial infarction, hemiplegia and painful conditions of neck and shoulder, such as trauma, tumors, cervical discogenic or intraforaminal diseases and shoulder calcific tendinopathy. And in rare cases it can also be seen associated with herpetic infections, tumors of brain and lungs, thoracoplasty and with certain drugs like phenobarbitone and isoniazid.
The exact pathophysiology of this syndrome isn't well understood but may involve a predominant sympathetic factor affecting the neural and vascular supply to the affected parts3.
The symptoms may vary over time and also shows inter individual variability. The primary symptoms include pain, swelling, redness, noticeable changes in temperature and hypersensitivity (particularly to cold and touch). As the time progresses, the affected limb can become cold and pale which may then undergo skin and nail changes as well as muscle spasms and tightening. Thus the condition becomes irreversible. The diagnosis of shoulder-hand syndrome in most cases is clinical, but imaging studies, particularly bone scintigraphy, can be useful to differentiate it from other disorders4.Treatment is likely to be most effective when started early in the course of the illness and even complete remission is possible.
CASE REPORT:
A 52-year-old female patient was admitted in general medicine department with complaints of neck pain for 1½ years, edema in both legs and restriction in movement of the left shoulder. She had a medical history of diabetes and hypertension. For diabetes she was under the treatment with T. Glycomet -500 mg (Metformin). Hypertension was managed by T.Telista -40 mg (Telmisartan) .The patient was advised to take CT scan of brain, MR Imaging of cervical spine, ECG, ECHO.
Table 1 : CT scan of brain plain study and mr imaging of cervical spine, ECHO
|
CT SACN OF BRAIN-PLAIN STUDY IMPRESSION SHOWS |
|
Chronic infarct with gliotic changes in the right frontal and right posterior parietal region in the watershed territory. Chronic infarct also noted in the right parietal sub cortical region. |
|
Few small faint hypodensity in the left posterior high parietal region and left parasagittal frontal region-Probably acute infarct. |
|
Small polypoidal mucosal thickening noted in the right maxillary sinus. |
|
MR IMAGING OF CERVICAL SPINE IMPRESSION SHOWS |
|
Flowing anterior syndesmophytes at C3 to C6 levels, favouring DISH. |
|
Mild lower cervicallevoscoliosis. |
|
Mild posterior central bulge at C2-3 and C3-4 levels. |
|
Mild posterior central disc osteophytic bulge at C4-5 level. |
|
Mild to moderate sized broad based right paracentral disc osteophyte protrusion at C5-6 level midlyindending adjacent cord. |
|
Cervical canal stenosis at C3-C6 levels. |
Table 2 : Echo report and summaray of ECHO ECG
|
|
|
ECHO SUMMARAY |
|
LA/LV not dilated .NO RWMA |
|
Valves /pericardium normal. |
|
Septae intact. No MR/PAH/PE |
|
Good LV systolic function. LVDD+ |
Table 3: ECG report and ECG summaray
|
|
|
ECG SUMMARAY |
|
Normal sinus rhythm |
|
Normal ECG |
The report shows normal ECG and ECHO and changes in the CT brain and MRI of cervical spine.
Laboratory investigations of the patients were as follows and shows elevation in the lymphocytes (35.7%), ESR(36 mm/hr.), RBS(321mg/dl). FBS of the patient were as follows 327 mg/dl on first day,108 mg/dl on second day, 140mg/dl on third day,85 mg/dl on fourth day and 180mg/dl on last day of the hospital stay. Pharamacological treatment provided to the patient are Inj. Renerve plus for nerve pain which is a combination of methylcobalamin(1000mcg), niacinamide (100mg) and pyridoineHcl (100 mg) in 100 ml Normal saline, T.torsemide(20 mg) for edema once daily in the morning, T.Glycomet (Metformin) and Inj.H.Actrapid (20 units s/c) for treatment of diabetes. T.Telista (Telmisartan-40 mg) for treatment of hypertension, T.Gabapentin (100 mg) is given for nerve pain, T.Zerodol S(Aceclofenac-100 mg+Serratiopeptidase- 15 mg) for treatment of pain and inflammation.T.lesuride (Levosulphride-25 MG) was given to the patient in the last two days of hospital stay as the patient experience gastric irritation.
CONCLUSION:
Multiple opinions remain with respect to an optimal treatment option for the shoulder hand syndrome even though much has been recommended literally5. Early diagnosis and treatment is most effective and can completely reverse the disease progression. The current therapy mainly focusses on alleviating the signs and symptoms of the disease rather than actual cure. A multifaceted approach integrating pharmacotherapy, physiotherapy and psychological therapy is most beneficial.
REFERENCE:
1. Ghai B, Dureja G. Complex regional pain syndrome: A review. J Postgrad Med [serial online] 2004 [cited 2022 Jul 18]; 50:300-7. Available from: https://www.jpgmonline.com/text.asp?2004/50/4/300/13655
2. Steinbrocker O., Argyros, T.G. (1958). The shoulder-hand syndrome: present status as a diagnostic and therapeutic entity. The Medical clinics of North America, 42(6), 1533–1553. https://doi.org/10.1016/s0025-7125(16)34203-1
3. Massarotti M., Ciocia G., Ceriani R. et al. Metastatic gastric cancer presenting with shoulder-hand syndrome: a case report. J Med Case Reports 2, 240 (2008). https://doi.org/10.1186/1752-1947-2-240
4. Low P.A., Amadio P.C., Wilson P.R., McManis P.G., Willner C.L. (1994). Laboratory findings in reflex sympathetic dystrophy: a preliminary report. The Clinical Journal of Pain, 10(3), 235–239. https://doi.org/10.1097/00002508-199409000-00010
5. Johnson EW, Pannozzo AN. Management of Shoulder-Hand Syndrome. JAMA. 1966;195(2):108–110. http://doi:10.1001/jama.1966.03100020096023
Received on 11.09.2021 Modified on 07.04.2022
Accepted on 18.07.2022 © RJPT All right reserved
Research J. Pharm. and Tech 2023; 16(3):1118-1120.
DOI: 10.52711/0974-360X.2023.00186